Welcome to AppLovin's earnings call for the fourth quarter and year ended December 31st, 2024. I'm David Hsiao, head o ...

Welcome to AppLovin's Earnings Call for the Fourth Quarter and Year ended December 31, 2024. I'm David Hsiao, Head of Investor Relations. Joining me today to discuss our results are Adam Foroughi, our ...

and its cutting-edge technology using disease-free, nontoxic replication-defective Herpes Simplex Virus, ("rdHSV"), vectors. The company currently has two therapeutic programs in development, ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal exc ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's results. Click for this VYGR update.

Cyber Security Consulting Services Market is Segmented by Type (Vulnerability Assessment and Penetration Testing, Security Audit, Incident Response, Compliance Testing), by Application (Government, ...

Operator Greetings, and welcome to the Varonis Systems, Inc. fourth quarter 2024 earnings conference call. At this time all ...

CISOs’ resolutions for 2025 will involve cultural shifts in risk management and collaboration between security and other ...

Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated ...

A team of researchers from the University of Science and Technology of China (USTC) has recently developed a lightweight prosthetic hand with 19 degrees of freedom (DOF), capable of replicating human ...

The future of manufacturing is not just about machines and AI; it's about re-empowering humans, according to a new study.

In the assessment of 12-month price targets, analysts unveil insights for 4D Molecular Therapeutics, presenting an average ...